Literature DB >> 20729804

Generation of recombinant influenza virus from plasmid DNA.

Luis Martínez-Sobrido1, Adolfo García-Sastre.   

Abstract

Efforts by a number of influenza research groups have been pivotal in the development and improvement of influenza A virus reverse genetics. Originally established in 1999 plasmid-based reverse genetic techniques to generate recombinant viruses have revolutionized the influenza research field because specific questions have been answered by genetically engineered, infectious, recombinant influenza viruses. Such studies include virus replication, function of viral proteins, the contribution of specific mutations in viral proteins in viral replication and/or pathogenesis and, also, viral vectors using recombinant influenza viruses expressing foreign proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729804      PMCID: PMC3156010          DOI: 10.3791/2057

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  5 in total

1.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

2.  Attenuation of equine influenza viruses through truncations of the NS1 protein.

Authors:  Michelle Quinlivan; Dmitriy Zamarin; Adolfo García-Sastre; Ann Cullinane; Thomas Chambers; Peter Palese
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Generation of influenza A viruses entirely from cloned cDNAs.

Authors:  G Neumann; T Watanabe; H Ito; S Watanabe; H Goto; P Gao; M Hughes; D R Perez; R Donis; E Hoffmann; G Hobom; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 4.  Plasmid-only rescue of influenza A virus vaccine candidates.

Authors:  J H Schickli; A Flandorfer; T Nakaya; L Martinez-Sobrido; A García-Sastre; P Palese
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

5.  Rescue of influenza A virus from recombinant DNA.

Authors:  E Fodor; L Devenish; O G Engelhardt; P Palese; G G Brownlee; A García-Sastre
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

  5 in total
  71 in total

1.  A novel eight amino acid insertion contributes to the hemagglutinin cleavability and the virulence of a highly pathogenic avian influenza A (H7N3) virus in mice.

Authors:  Xiangjie Sun; Jessica A Belser; Terrence M Tumpey
Journal:  Virology       Date:  2015-11-26       Impact factor: 3.616

2.  Functional Evolution of Influenza Virus NS1 Protein in Currently Circulating Human 2009 Pandemic H1N1 Viruses.

Authors:  Amelia M Clark; Aitor Nogales; Luis Martinez-Sobrido; David J Topham; Marta L DeDiego
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

3.  Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.

Authors:  Aitor Nogales; Laura Rodriguez; Marta L DeDiego; David J Topham; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

4.  Replication-Competent Influenza B Reporter Viruses as Tools for Screening Antivirals and Antibodies.

Authors:  Benjamin O Fulton; Peter Palese; Nicholas S Heaton
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

5.  A point mutation in the polymerase protein PB2 allows a reassortant H9N2 influenza isolate of wild-bird origin to replicate in human cells.

Authors:  Islam T M Hussein; Eric J Ma; Nichola J Hill; Brandt W Meixell; Mark Lindberg; Randy A Albrecht; Justin Bahl; Jonathan A Runstadler
Journal:  Infect Genet Evol       Date:  2016-04-14       Impact factor: 3.342

6.  Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA).

Authors:  Steven F Baker; Aitor Nogales; Felix W Santiago; David J Topham; Luis Martínez-Sobrido
Journal:  Vaccine       Date:  2015-06-01       Impact factor: 3.641

7.  Identification of key hemagglutinin residues responsible for cleavage, acid stability, and virulence of fifth-wave highly pathogenic avian influenza A(H7N9) viruses.

Authors:  Xiangjie Sun; Jessica A Belser; Hua Yang; Joanna A Pulit-Penaloza; Claudia Pappas; Nicole Brock; Hui Zeng; Hannah M Creager; James Stevens; Taronna R Maines
Journal:  Virology       Date:  2019-07-12       Impact factor: 3.616

8.  Arenavirus reverse genetics for vaccine development.

Authors:  Emilio Ortiz-Riaño; Benson Yee Hin Cheng; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  J Gen Virol       Date:  2013-01-30       Impact factor: 3.891

9.  In vivo analysis of influenza A mRNA secondary structures identifies critical regulatory motifs.

Authors:  Lisa Marie Simon; Edoardo Morandi; Anna Luganini; Giorgio Gribaudo; Luis Martinez-Sobrido; Douglas H Turner; Salvatore Oliviero; Danny Incarnato
Journal:  Nucleic Acids Res       Date:  2019-07-26       Impact factor: 16.971

10.  Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development.

Authors:  Aitor Nogales; Steven F Baker; Emilio Ortiz-Riaño; Stephen Dewhurst; David J Topham; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.